mRNA Vaccines for Infectious Diseases Market, Global Outlook and Forecast 2022-2028

0
3

This report contains market size and forecasts of mRNA Vaccines for Infectious Diseases in Global, including the following market information:
Global mRNA Vaccines for Infectious Diseases Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global mRNA Vaccines for Infectious Diseases market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Infectious Disease Vaccines Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of mRNA Vaccines for Infectious Diseases include Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics, In-Cell-Art, eTheRNA and Ethris and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the mRNA Vaccines for Infectious Diseases companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global mRNA Vaccines for Infectious Diseases Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global mRNA Vaccines for Infectious Diseases Market Segment Percentages, by Type, 2021 (%)
Infectious Disease Vaccines
Cancer Vaccines
Global mRNA Vaccines for Infectious Diseases Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global mRNA Vaccines for Infectious Diseases Market Segment Percentages, by Application, 2021 (%)
Infectious Disease
Cancer
Global mRNA Vaccines for Infectious Diseases Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global mRNA Vaccines for Infectious Diseases Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies mRNA Vaccines for Infectious Diseases revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies mRNA Vaccines for Infectious Diseases revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.